Gender Ideology – Definition for Briefing Notes – Overview: Over recent years, trans-hostile actors and right-wing members of the Conservative…
Browsing: Briefing Notes
Briefing Notes For MPs and Media
TransLucent briefing notes are produced for MPs and journalists alike, giving basic details of human rights issues facing the trans community, probably the most marginalised, vulnerable and attacked demographic in British society today.
Victims of far-right, “gender-critical” organisations with seemingly unlimited funds (often from evangelical sources), a culture war against the trans community, which started in 2017, see no signs of abating.
The UK trans community consists of approximately 250,000 people, roughly the same size as the Jewish community. Approximately 50,000 people identify as trans women, with a similar number identifying as trans men, the residue often being non-binary.
Many trans people have mental health issues, often because of difficulty in getting a job (one in three employers admit they are sceptical about employing a trans person) and the delay in getting gender-affirming healthcare via the NHS, which on average is around eight years.
For additional information on any trans related topic, please email: contact@translucent.org.uk
Transgender Children’s Healthcare in the UK – Navigating the Complexities As a Transgender Advocacy Organisation, we receive many requests from…
Briefing Notes – For MPs and Media – Transgender Hate Crime in the UK Our briefing notes for MP’s and…
The TransLucent briefing notes are for MPs and journalists, giving details on human rights issues facing the trans community, a marginalised and vulnerable demographic.
Continue Reading Briefing Notes For MPs and Media
Reforming the Gender Recognition Act 2004 – A Briefing Note for MPs The purpose of this briefing paper is to…
TransLucent’s position statement argues against the ban on puberty blockers (GnRH analogues) for young trans people, citing insufficient evidence and potential bias in the Cass Review. Continue Reading TransLucent Puberty Blocker (GnRH Analogues) Position Statement